<?xml version="1.0" encoding="UTF-8" ?><rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xml:lang="en">
<channel rdf:about="http://www.giiresearch.com/topics/PH15_en.shtml">
  <title>Market Research Reports for Cancer</title>
  <link>http://www.giiresearch.com/topics/PH15_en.shtml</link>
  <description>Market Research Reports for Cancer</description>
  <dc:publisher>Global Information, Inc.</dc:publisher>
  <dc:rights>(C) 2013 Global Information, Inc.</dc:rights>
  <dc:date>2013-05-17</dc:date>
  <sy:updatePeriod>daily</sy:updatePeriod>
  <items>
    <rdf:Seq>
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237413-2012-france-cancer-diagnostics-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237414-2012-germany-cancer-diagnostics-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237415-2012-italy-cancer-diagnostics-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237416-2012-japan-cancer-diagnostics-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237417-2012-spain-cancer-diagnostics-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237418-2012-uk-cancer-diagnostics-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237419-2012-us-cancer-diagnostics-market-outlook-growth.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/wild238158-cancer-monoclonal-antibody-partnering-terms.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kl270517-world-market-cancer-diagnostics-5th-edition.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid86340-ch-lymphoma-treat.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid100198-china-anti-tumor.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/tk203885-cancer-diagnostic-testing-world-markets.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166026-antibodi-pepti-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166029-breast-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166034-cancer-immunothera.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166037-cancer-thera-antibo.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166070-colorectal-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166071-hematologi-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166075-lymphoma.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166077-pancreatic-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166078-peptides-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166079-prostate-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg166080-onco-protein-kinase.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167147-alpha6-beta4-integr.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167148-androgen-recept.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167150-angiogene-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167159-antibodies-in-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167160-apoptosis-in-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167162-b-cell-receptor.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167164-biologicals-in-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg167165-bladder-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171731-brain-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171732-breast-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171733-cancer-vaccines.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171735-cellular-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171737-colorectal-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171744-cytokine-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171745-egfr1-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171746-gene-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171747-head-neck-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171748-hedgehog-signal-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171749-hematological-cancers.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171750-id-signaling-p-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171751-il1-signaling-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171752-il2-signaling-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171753-il-3-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171754-il-4-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171755-il5-signaling-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171756-il-6-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171757-il-7-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171758-il-9-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171759-immunotherapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171761-kit-receptor.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171762-leukemia-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171763-liver-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171765-lung-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171766-lymphoma-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171767-melanoma-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171768-neuroendocrine-tumor.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171769-notch-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171770-nucleic-acid.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171772-ovarian-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171774-pancreatic-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171783-peptides-oncology.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171784-prostate-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171785-protein-kinase.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171786-proteins-oncology.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171788-radiation-therapy.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171789-renal-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171790-rna-interference.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171791-t-cell-receptor-signal.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171792-tgf-beta-rece-signal.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171793-tnf-alpha-signal.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg171794-wnt-signaling.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg191458-leukemia.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg207057-analytical-tool-lung-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg227316-analytical-tool-apoptosis-oncology.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg230994-analytical-tool-angiogenesis-oncology.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg232960-analytical-tool-cancer-vaccines.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg232961-analytical-tool-melanoma.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg232962-fsh-signaling-pathway-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg232968-leptin-signaling-pathway-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg232969-rankl-signaling-pathway-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg232970-tsh-signaling-pathway-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg232971-tslp-signaling-pathway-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg251307-cancer-stem-cells-drug-pipeline-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263208-epigenetic-therapy-oncology-drug-pipeline-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263209-adherens-junction-targeting-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263210-calcium-signaling-pathway-cancer-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263211-targeting-cell-adhesion-molecules-cams-treatment.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263212-cell-cycle-targeting-cancer-drug-pipeline-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263213-interfering-cytokine-cytokine-receptor-interaction.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263214-interfering-ecm-receptor-interaction-treatment.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263215-fc-epsilon-ri-signaling-pathway-oncology-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263216-targeting-focal-adhesion-treatment-cancer-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263217-gap-junctions-oncology-drug-pipeline-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263218-gnrh-signaling-pathway-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263219-jak-stat-signaling-pathway-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263220-mapk-signaling-pathway-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263221-mtor-signaling-pathway-oncology-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263222-targeting-natural-killer-cell-mediated.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263223-modulators-actin-cytoskeleton-treatment-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263224-targeting-tight-junctions-cancer-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263225-toll-like-receptor-signaling-pathway-cancer-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263226-vegf-signaling-pathway-cancer-drug-pipeline-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263227-rig-i-like-receptor-signaling-pathway-cancer-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263229-nod-like-receptor-signaling-pathway-cancer-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263230-p53-signaling-pathway-cancer-drug-pipeline-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263231-targeting-metabolic-pathways-cancer-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263232-erbb-signaling-pathway-cancer-drug-pipeline-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263233-chemokine-signaling-pathway-cancer-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263234-pi3k-akt-signaling-pathway-cancer-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263235-transcriptional-misregulation-cancer-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263236-viral-carcinogenesis-drug-pipeline-update.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263237-hif-1-signaling-pathway-cancer-drug-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg233488-2012-european-cancer-diagnostics-market-france.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg166153-cea-testing.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237646-2012-global-ca-tumor-markers-diagnostics-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd268831-epicast-report-chronic-myeloid-leukemia.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi268581-oncology-therapeutics-market-india-introduction.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/tk203890-molecular-diagnostics-cancer-testing.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/jai70928-drug-deli.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dgpl270390-consensus-outlook-prostate-cancer-competition.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi268580-therapeutic-cancer-vaccines-market-pipeline.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd268834-epicast-report-non-small-cell-lung-cancer-nsclc.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg268471-cancer-vaccines-from-first-class-best-class.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/cei264527-ocology-clinical-trials-drug-development-resources.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/infi264450-global-kidney-cancer-drugs-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/infi264451-global-leukemia-therapeutics-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/infi264442-global-next-generation-cancer-diagnostic-devices.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dgpl268897-kol-insight-prostate-cancer-competition.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg237411-2012-global-cancer-diagnostics-market-outlook.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263205-oncology-drug-pipeline-update-premium-online.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg263207-oncology-drug-pipeline-update-premium.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg261390-analysis-global-cancer-diagnostics-market-emerging.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/es51959-alcon.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/infi261559-global-lung-cancer-therapeutics-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/infi261548-global-non-small-cell-lung-cancer-drugs-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc263117-pipeline-renal-cell-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd217232-melanoma-global-clinical-trials-review-h2-2011.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd217238-bone-metastasis-global-clinical-trials-review-h2.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg243230-oncology-drug-pathway-analyzer-standard-version.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg243231-oncology-drug-pathway-analyzer-premium-version.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg259779-oncology-drug-pathway-analyzer-premium-online.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/infi260034-global-cancer-biomarkers-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/vpg258887-us-hospital-tumor-marker-testing-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/sb227611-circulating-tumor-cells-ctcs-cancer-stem-cells.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg259016-cancer-peptides-from-first-class-best-class.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/grey135878-clos-drug-trans-onco.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc257331-prevention-treatment-prostate-cancer-technologies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi258791-liver-cancer-therapeutics-market-nexavar-only.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262444-pharmapoint-prostate-cancer-united-states-drug.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262446-pharmapoint-prostate-cancer-france-drug-forecast.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262450-pharmapoint-prostate-cancer-japan-drug-forecast.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262469-zoladex-prostate-cancer-forecast-market-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262470-lupron-depot-prostate-cancer-forecast-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262471-eligard-prostate-cancer-forecast-market-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262472-trelstar-prostate-cancer-forecast-market-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262473-firmagon-prostate-cancer-forecast-market-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262474-jevtana-prostate-cancer-forecast-market-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262475-provenge-prostate-cancer-forecast-market-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262476-zytiga-prostate-cancer-forecast-market-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262477-xtandi-prostate-cancer-forecast-market-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262478-xgeva-prostate-cancer-forecast-market-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262479-zometa-prostate-cancer-forecast-market-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262480-cabozantinib-prostate-cancer-forecast-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262481-custirsen-sodium-prostate-cancer-forecast-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262482-sprycel-prostate-cancer-forecast-market-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262483-yervoy-prostate-cancer-forecast-market-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262484-orteronel-prostate-cancer-forecast-market-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262485-alpharadin-prostate-cancer-forecast-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262486-tasquinimod-prostate-cancer-forecast-market.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd262487-prostvac-prostate-cancer-forecast-market-analysis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd263601-pharmapoint-prostate-cancer-current-future-players.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd258691-epicast-report-colorectal-cancer-epidemiology.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc258417-forecast-non-small-cell-lung-cancer-china.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kt226942-small-molecule-targeted-cancer-therapies-world.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc258416-treatment-non-small-cell-lung-cancer-china.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/kl258246-next-wave-cancer-treatment-kinase-inhibitors.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bc256178-oncology-market-research-review.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gd212843-cervical-cancer-global-clinical-trials-review-h2.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr270349-treatmenttrends-advanced-metastatic-breast-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr270345-oncology-patient-flow-model-ovarian-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr270339-launchtrends-enzalutimide-xtandi-wave-1-us.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr270336-innovative-r-d-dealmaking-opportunities-oncology.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr270272-chemotherapy-induced-nausea-vomiting-how-are.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr270344-oncology-patient-flow-model-non-small-cell-lung.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr270354-treatmenttrends-non-small-cell-lung-cancer-eu.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc256959-hemophilia-pipeline-overview-once-week-prophylaxis.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr270340-launchtrends-xalkori-wave-3.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dr270343-oncology-patient-flow-model-head-neck-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/fs253869-united-states-oncology-drug-delivery-preferences.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/tk243424-game-changers-breast-cancer-therapies.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/gbi253371-leukemia-therapeutics-market-strong-late-stage.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/bg254187-cancer-antibodies-drug-target-atlas-competitive.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/tsm253512-cervical-cancer-diagnostic-tests-pap-smear.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc254480-market-product-forecasts-melanoma-yervoy-will.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/dc254476-treatment-algorithms-non-small-cell-lung-cancer.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/amid125555-china-cancer-treatment.html" />
      <rdf:li rdf:resource="http://www.giiresearch.com/report/cd251782-therapies-solid-tumors-pipelines-markets-business.html" />
    </rdf:Seq>
  </items>
</channel>
<item rdf:about="http://www.giiresearch.com/report/vpg237413-2012-france-cancer-diagnostics-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>French Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237413-2012-france-cancer-diagnostics-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237414-2012-germany-cancer-diagnostics-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>German Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237414-2012-germany-cancer-diagnostics-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237415-2012-italy-cancer-diagnostics-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Italian Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237415-2012-italy-cancer-diagnostics-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237416-2012-japan-cancer-diagnostics-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Japanese Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237416-2012-japan-cancer-diagnostics-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237417-2012-spain-cancer-diagnostics-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Spanish Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237417-2012-spain-cancer-diagnostics-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237418-2012-uk-cancer-diagnostics-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>UK Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237418-2012-uk-cancer-diagnostics-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237419-2012-us-cancer-diagnostics-market-outlook-growth.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-05-16</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>US Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg237419-2012-us-cancer-diagnostics-market-outlook-growth.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/wild238158-cancer-monoclonal-antibody-partnering-terms.html">
  <dc:language>en</dc:language>
  <dc:subject>Biologics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2013-05-08</dc:date>
  <dc:creator>Current Partnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Cancer Monoclonal Antibody Partnering Terms and Agreements</title>
  <link>http://www.giiresearch.com/report/wild238158-cancer-monoclonal-antibody-partnering-terms.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kl270517-world-market-cancer-diagnostics-5th-edition.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-05-08</dc:date>
  <dc:creator>Kalorama Information</dc:creator>
  <title>The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives</title>
  <link>http://www.giiresearch.com/report/kl270517-world-market-cancer-diagnostics-5th-edition.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid86340-ch-lymphoma-treat.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Lymphoma Treatment Drugs Markets in China</title>
  <link>http://www.giiresearch.com/report/amid86340-ch-lymphoma-treat.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid100198-china-anti-tumor.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Anti-Tumor Drugs Markets in China</title>
  <link>http://www.giiresearch.com/report/amid100198-china-anti-tumor.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/tk203885-cancer-diagnostic-testing-world-markets.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Biotechnology Equipment</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-05-01</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>Cancer Diagnostic Testing World Markets</title>
  <link>http://www.giiresearch.com/report/tk203885-cancer-diagnostic-testing-world-markets.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166026-antibodi-pepti-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Biologics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Antibodies and Peptides in Oncology</title>
  <link>http://www.giiresearch.com/report/bg166026-antibodi-pepti-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166029-breast-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Breast Cancer</title>
  <link>http://www.giiresearch.com/report/bg166029-breast-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166034-cancer-immunothera.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Cancer Immunotherapy</title>
  <link>http://www.giiresearch.com/report/bg166034-cancer-immunothera.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166037-cancer-thera-antibo.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Cancer Therapeutic Antibodies</title>
  <link>http://www.giiresearch.com/report/bg166037-cancer-thera-antibo.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166070-colorectal-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Colorectal Cancer</title>
  <link>http://www.giiresearch.com/report/bg166070-colorectal-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166071-hematologi-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Hematological Cancers</title>
  <link>http://www.giiresearch.com/report/bg166071-hematologi-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166075-lymphoma.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Lymphoma</title>
  <link>http://www.giiresearch.com/report/bg166075-lymphoma.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166077-pancreatic-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Pancreatic Cancer</title>
  <link>http://www.giiresearch.com/report/bg166077-pancreatic-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166078-peptides-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Peptides in Oncology</title>
  <link>http://www.giiresearch.com/report/bg166078-peptides-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166079-prostate-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Prostate Cancer</title>
  <link>http://www.giiresearch.com/report/bg166079-prostate-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg166080-onco-protein-kinase.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Molecular Targeted Therapeutics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Protein Kinase Inhibitors in Oncology</title>
  <link>http://www.giiresearch.com/report/bg166080-onco-protein-kinase.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167147-alpha6-beta4-integr.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167147-alpha6-beta4-integr.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167148-androgen-recept.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167148-androgen-recept.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167150-angiogene-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Angiogenesis in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167150-angiogene-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167159-antibodies-in-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Antibodies in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167159-antibodies-in-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167160-apoptosis-in-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Apoptosis in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167160-apoptosis-in-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167162-b-cell-receptor.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>B Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167162-b-cell-receptor.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167164-biologicals-in-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Biologicals in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167164-biologicals-in-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg167165-bladder-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Bladder Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg167165-bladder-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171731-brain-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Brain Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171731-brain-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171732-breast-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Breast Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171732-breast-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171733-cancer-vaccines.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Vaccines</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Cancer Vaccines Drug Pipeline 2013</title>
  <link>http://www.giiresearch.com/report/bg171733-cancer-vaccines.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171735-cellular-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Cellular Therapy in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171735-cellular-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171737-colorectal-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Colorectal Cancer Drug Pipeline 2013</title>
  <link>http://www.giiresearch.com/report/bg171737-colorectal-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171744-cytokine-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Cytokine Therapy in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171744-cytokine-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171745-egfr1-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171745-egfr1-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171746-gene-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Gene Therapy in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171746-gene-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171747-head-neck-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Head and Neck Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171747-head-neck-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171748-hedgehog-signal-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171748-hedgehog-signal-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171749-hematological-cancers.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Hematological Cancers Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171749-hematological-cancers.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171750-id-signaling-p-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>ID Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171750-id-signaling-p-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171751-il1-signaling-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-1 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171751-il1-signaling-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171752-il2-signaling-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171752-il2-signaling-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171753-il-3-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-3 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171753-il-3-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171754-il-4-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-4 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171754-il-4-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171755-il5-signaling-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-5 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171755-il5-signaling-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171756-il-6-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-6 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171756-il-6-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171757-il-7-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-7 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171757-il-7-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171758-il-9-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>IL-9 Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171758-il-9-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171759-immunotherapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Immunotherapy in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171759-immunotherapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171761-kit-receptor.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Kit Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171761-kit-receptor.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171762-leukemia-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Leukemia Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171762-leukemia-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171763-liver-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Liver Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171763-liver-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171765-lung-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Lung Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171765-lung-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171766-lymphoma-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Lymphoma Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171766-lymphoma-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171767-melanoma-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Melanoma Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171767-melanoma-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171768-neuroendocrine-tumor.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Neuroendocrine Tumors Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171768-neuroendocrine-tumor.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171769-notch-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Notch Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171769-notch-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171770-nucleic-acid.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Nucleic Acid Therapies in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171770-nucleic-acid.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171772-ovarian-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Ovarian Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171772-ovarian-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171774-pancreatic-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Pancreatic Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171774-pancreatic-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171783-peptides-oncology.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Peptides in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171783-peptides-oncology.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171784-prostate-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Prostate Cancer Drug Pipeline Update 2012</title>
  <link>http://www.giiresearch.com/report/bg171784-prostate-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171785-protein-kinase.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Molecular Targeted Therapeutics</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Protein Kinase Inhibitors in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171785-protein-kinase.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171786-proteins-oncology.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Proteins in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171786-proteins-oncology.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171788-radiation-therapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Radiation Therapy in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171788-radiation-therapy.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171789-renal-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Renal Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171789-renal-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171790-rna-interference.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Gene Therapeutics &amp; RNAi</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>RNA Interference Therapy in Oncology Drug Pipeline Update 2012</title>
  <link>http://www.giiresearch.com/report/bg171790-rna-interference.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171791-t-cell-receptor-signal.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171791-t-cell-receptor-signal.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171792-tgf-beta-rece-signal.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171792-tgf-beta-rece-signal.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171793-tnf-alpha-signal.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg171793-tnf-alpha-signal.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg171794-wnt-signaling.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Wnt Signaling Pathway in Oncology Drug Pipeline Update 2012</title>
  <link>http://www.giiresearch.com/report/bg171794-wnt-signaling.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg191458-leukemia.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Leukemia</title>
  <link>http://www.giiresearch.com/report/bg191458-leukemia.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg207057-analytical-tool-lung-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Lung Cancer</title>
  <link>http://www.giiresearch.com/report/bg207057-analytical-tool-lung-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg227316-analytical-tool-apoptosis-oncology.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Apoptosis in Oncology</title>
  <link>http://www.giiresearch.com/report/bg227316-analytical-tool-apoptosis-oncology.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg230994-analytical-tool-angiogenesis-oncology.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Angiogenesis in Oncology</title>
  <link>http://www.giiresearch.com/report/bg230994-analytical-tool-angiogenesis-oncology.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg232960-analytical-tool-cancer-vaccines.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Vaccines</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Cancer Vaccines</title>
  <link>http://www.giiresearch.com/report/bg232960-analytical-tool-cancer-vaccines.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg232961-analytical-tool-melanoma.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Analytical Tool - Melanoma</title>
  <link>http://www.giiresearch.com/report/bg232961-analytical-tool-melanoma.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg232962-fsh-signaling-pathway-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>FSH Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg232962-fsh-signaling-pathway-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg232968-leptin-signaling-pathway-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Leptin Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg232968-leptin-signaling-pathway-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg232969-rankl-signaling-pathway-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>RANKL Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg232969-rankl-signaling-pathway-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg232970-tsh-signaling-pathway-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>TSH Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg232970-tsh-signaling-pathway-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg232971-tslp-signaling-pathway-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>TSLP Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg232971-tslp-signaling-pathway-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg251307-cancer-stem-cells-drug-pipeline-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Cancer Stem Cells Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg251307-cancer-stem-cells-drug-pipeline-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263208-epigenetic-therapy-oncology-drug-pipeline-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Epigenetic Therapy in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263208-epigenetic-therapy-oncology-drug-pipeline-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263209-adherens-junction-targeting-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Adherens Junction Targeting in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263209-adherens-junction-targeting-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263210-calcium-signaling-pathway-cancer-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Calcium Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263210-calcium-signaling-pathway-cancer-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263211-targeting-cell-adhesion-molecules-cams-treatment.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Targeting Cell Adhesion Molecules (CAMs) for the Treatment of Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263211-targeting-cell-adhesion-molecules-cams-treatment.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263212-cell-cycle-targeting-cancer-drug-pipeline-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Cell Cycle Targeting in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263212-cell-cycle-targeting-cancer-drug-pipeline-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263213-interfering-cytokine-cytokine-receptor-interaction.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Interfering With Cytokine-Cytokine Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263213-interfering-cytokine-cytokine-receptor-interaction.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263214-interfering-ecm-receptor-interaction-treatment.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Interfering With the ECM-Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263214-interfering-ecm-receptor-interaction-treatment.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263215-fc-epsilon-ri-signaling-pathway-oncology-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Fc Epsilon RI Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263215-fc-epsilon-ri-signaling-pathway-oncology-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263216-targeting-focal-adhesion-treatment-cancer-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Targeting Focal Adhesion for the Treatment of Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263216-targeting-focal-adhesion-treatment-cancer-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263217-gap-junctions-oncology-drug-pipeline-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Gap Junctions in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263217-gap-junctions-oncology-drug-pipeline-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263218-gnrh-signaling-pathway-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>GnRH Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263218-gnrh-signaling-pathway-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263219-jak-stat-signaling-pathway-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Jak-STAT Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263219-jak-stat-signaling-pathway-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263220-mapk-signaling-pathway-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>The MAPK Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263220-mapk-signaling-pathway-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263221-mtor-signaling-pathway-oncology-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>mTOR Signaling Pathway in Oncology Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263221-mtor-signaling-pathway-oncology-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263222-targeting-natural-killer-cell-mediated.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Targeting Natural Killer Cell Mediated Cytotoxicity in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263222-targeting-natural-killer-cell-mediated.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263223-modulators-actin-cytoskeleton-treatment-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Modulators of the Actin Cytoskeleton for the Treatment of Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263223-modulators-actin-cytoskeleton-treatment-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263224-targeting-tight-junctions-cancer-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Targeting Tight Junctions in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263224-targeting-tight-junctions-cancer-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263225-toll-like-receptor-signaling-pathway-cancer-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Toll-Like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263225-toll-like-receptor-signaling-pathway-cancer-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263226-vegf-signaling-pathway-cancer-drug-pipeline-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>VEGF Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263226-vegf-signaling-pathway-cancer-drug-pipeline-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263227-rig-i-like-receptor-signaling-pathway-cancer-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>RIG-I-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263227-rig-i-like-receptor-signaling-pathway-cancer-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263229-nod-like-receptor-signaling-pathway-cancer-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>NOD-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263229-nod-like-receptor-signaling-pathway-cancer-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263230-p53-signaling-pathway-cancer-drug-pipeline-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>p53 Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263230-p53-signaling-pathway-cancer-drug-pipeline-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263231-targeting-metabolic-pathways-cancer-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Targeting Metabolic Pathways in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263231-targeting-metabolic-pathways-cancer-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263232-erbb-signaling-pathway-cancer-drug-pipeline-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>ErbB Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263232-erbb-signaling-pathway-cancer-drug-pipeline-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263233-chemokine-signaling-pathway-cancer-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Chemokine Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263233-chemokine-signaling-pathway-cancer-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263234-pi3k-akt-signaling-pathway-cancer-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>PI3K-Akt Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263234-pi3k-akt-signaling-pathway-cancer-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263235-transcriptional-misregulation-cancer-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Transcriptional Misregulation in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263235-transcriptional-misregulation-cancer-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263236-viral-carcinogenesis-drug-pipeline-update.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Viral Carcinogenesis Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263236-viral-carcinogenesis-drug-pipeline-update.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263237-hif-1-signaling-pathway-cancer-drug-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-04-22</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2013</title>
  <link>http://www.giiresearch.com/report/bg263237-hif-1-signaling-pathway-cancer-drug-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg233488-2012-european-cancer-diagnostics-market-france.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-04-18</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the European Cancer Diagnostics Market: France, Germany, Italy, Spain, UK - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg233488-2012-european-cancer-diagnostics-market-france.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg166153-cea-testing.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the CEA Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg166153-cea-testing.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237646-2012-global-ca-tumor-markers-diagnostics-market.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-04-17</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the CA Tumor Markers Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape</title>
  <link>http://www.giiresearch.com/report/vpg237646-2012-global-ca-tumor-markers-diagnostics-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd268831-epicast-report-chronic-myeloid-leukemia.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-12</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>EpiCast Report: Chronic Myeloid Leukemia - Epidemiology Forecast to 2022</title>
  <link>http://www.giiresearch.com/report/gd268831-epicast-report-chronic-myeloid-leukemia.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi268581-oncology-therapeutics-market-india-introduction.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-08</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players</title>
  <link>http://www.giiresearch.com/report/gbi268581-oncology-therapeutics-market-india-introduction.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/tk203890-molecular-diagnostics-cancer-testing.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:date>2013-04-02</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>Molecular Diagnostics in Cancer Testing</title>
  <link>http://www.giiresearch.com/report/tk203890-molecular-diagnostics-cancer-testing.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/jai70928-drug-deli.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Delivery System</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Jain Pharmabiotech</dc:creator>
  <title>Drug Delivery in Cancer - technologies, markets and companies</title>
  <link>http://www.giiresearch.com/report/jai70928-drug-deli.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dgpl270390-consensus-outlook-prostate-cancer-competition.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-04-01</dc:date>
  <dc:creator>Doctor's Guide Publishing Limited (FirstWord Pharma)</dc:creator>
  <title>Consensus Outlook: Prostate Cancer- Competition intensifies in race to the top</title>
  <link>http://www.giiresearch.com/report/dgpl270390-consensus-outlook-prostate-cancer-competition.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi268580-therapeutic-cancer-vaccines-market-pipeline.html">
  <dc:language>en</dc:language>
  <dc:subject>Vaccines</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-03-31</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake</title>
  <link>http://www.giiresearch.com/report/gbi268580-therapeutic-cancer-vaccines-market-pipeline.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd268834-epicast-report-non-small-cell-lung-cancer-nsclc.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-03-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>EpiCast Report: Non-Small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2022</title>
  <link>http://www.giiresearch.com/report/gd268834-epicast-report-non-small-cell-lung-cancer-nsclc.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg268471-cancer-vaccines-from-first-class-best-class.html">
  <dc:language>en</dc:language>
  <dc:subject>Vaccines</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-03-19</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Cancer Vaccines: From First-in-Class to Best-in-Class?</title>
  <link>http://www.giiresearch.com/report/bg268471-cancer-vaccines-from-first-class-best-class.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/cei264527-ocology-clinical-trials-drug-development-resources.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-03-15</dc:date>
  <dc:creator>Cutting Edge Information</dc:creator>
  <title>Oncology Clinical Trials: Drug Development Resources and Case Studies</title>
  <link>http://www.giiresearch.com/report/cei264527-ocology-clinical-trials-drug-development-resources.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/infi264450-global-kidney-cancer-drugs-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2013-03-11</dc:date>
  <dc:creator>Infiniti Research Limited  (Technavio)</dc:creator>
  <title>Global Kidney Cancer Drugs Market 2012-2016</title>
  <link>http://www.giiresearch.com/report/infi264450-global-kidney-cancer-drugs-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/infi264451-global-leukemia-therapeutics-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-03-11</dc:date>
  <dc:creator>Infiniti Research Limited  (Technavio)</dc:creator>
  <title>Global Leukemia Therapeutics Market 2012-2016</title>
  <link>http://www.giiresearch.com/report/infi264451-global-leukemia-therapeutics-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/infi264442-global-next-generation-cancer-diagnostic-devices.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-03-07</dc:date>
  <dc:creator>Infiniti Research Limited  (Technavio)</dc:creator>
  <title>Global Next Generation Cancer Diagnostic Devices Market 2012-2016</title>
  <link>http://www.giiresearch.com/report/infi264442-global-next-generation-cancer-diagnostic-devices.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dgpl268897-kol-insight-prostate-cancer-competition.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-03-01</dc:date>
  <dc:creator>Doctor's Guide Publishing Limited (FirstWord Pharma)</dc:creator>
  <title>KOL Insight: Prostate Cancer: Competition intensifies in race to the top</title>
  <link>http://www.giiresearch.com/report/dgpl268897-kol-insight-prostate-cancer-competition.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg237411-2012-global-cancer-diagnostics-market-outlook.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-02-15</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>Competing in the Global Cancer Diagnostics Market</title>
  <link>http://www.giiresearch.com/report/vpg237411-2012-global-cancer-diagnostics-market-outlook.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263205-oncology-drug-pipeline-update-premium-online.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-02-12</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Oncology Drug Pipeline Update (Premium) - Online</title>
  <link>http://www.giiresearch.com/report/bg263205-oncology-drug-pipeline-update-premium-online.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg263207-oncology-drug-pipeline-update-premium.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-02-12</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Oncology Drug Pipeline Update (Premium)</title>
  <link>http://www.giiresearch.com/report/bg263207-oncology-drug-pipeline-update-premium.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg261390-analysis-global-cancer-diagnostics-market-emerging.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-02-06</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 Analysis of the Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers</title>
  <link>http://www.giiresearch.com/report/vpg261390-analysis-global-cancer-diagnostics-market-emerging.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/es51959-alcon.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Pharmaceutical Companies</dc:subject>
  <dc:date>2013-01-30</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Alcon: Company Intelligence Report</title>
  <link>http://www.giiresearch.com/report/es51959-alcon.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/infi261559-global-lung-cancer-therapeutics-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-01-18</dc:date>
  <dc:creator>Infiniti Research Limited  (Technavio)</dc:creator>
  <title>Global Lung Cancer Therapeutics Market 2012-2016</title>
  <link>http://www.giiresearch.com/report/infi261559-global-lung-cancer-therapeutics-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/infi261548-global-non-small-cell-lung-cancer-drugs-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-01-16</dc:date>
  <dc:creator>Infiniti Research Limited  (Technavio)</dc:creator>
  <title>Global Non-small Cell Lung Cancer Drugs Market 2012-2016</title>
  <link>http://www.giiresearch.com/report/infi261548-global-non-small-cell-lung-cancer-drugs-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc263117-pipeline-renal-cell-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-01-15</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Pipeline: Renal Cell Cancer</title>
  <link>http://www.giiresearch.com/report/dc263117-pipeline-renal-cell-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd217232-melanoma-global-clinical-trials-review-h2-2011.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-01-14</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Melanoma Global Clinical Trials Review, H1, 2013</title>
  <link>http://www.giiresearch.com/report/gd217232-melanoma-global-clinical-trials-review-h2-2011.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd217238-bone-metastasis-global-clinical-trials-review-h2.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-01-14</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Bone Metastasis Global Clinical Trials Review, H1, 2013</title>
  <link>http://www.giiresearch.com/report/gd217238-bone-metastasis-global-clinical-trials-review-h2.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg243230-oncology-drug-pathway-analyzer-standard-version.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-01-14</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Oncology Drug Pathway Analyzer (Standard Version)</title>
  <link>http://www.giiresearch.com/report/bg243230-oncology-drug-pathway-analyzer-standard-version.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg243231-oncology-drug-pathway-analyzer-premium-version.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-01-14</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Oncology Drug Pathway Analyzer (Premium Version)</title>
  <link>http://www.giiresearch.com/report/bg243231-oncology-drug-pathway-analyzer-premium-version.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg259779-oncology-drug-pathway-analyzer-premium-online.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-01-14</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Oncology Drug Pathway Analyzer (Premium) - Online</title>
  <link>http://www.giiresearch.com/report/bg259779-oncology-drug-pathway-analyzer-premium-online.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/infi260034-global-cancer-biomarkers-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomarker</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-01-11</dc:date>
  <dc:creator>Infiniti Research Limited  (Technavio)</dc:creator>
  <title>Global Cancer Biomarkers Market 2012-2016</title>
  <link>http://www.giiresearch.com/report/infi260034-global-cancer-biomarkers-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/vpg258887-us-hospital-tumor-marker-testing-market.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biomarker</dc:subject>
  <dc:date>2013-01-08</dc:date>
  <dc:creator>Venture Planning Group</dc:creator>
  <title>2013 US Hospital Tumor Marker Testing Market</title>
  <link>http://www.giiresearch.com/report/vpg258887-us-hospital-tumor-marker-testing-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/sb227611-circulating-tumor-cells-ctcs-cancer-stem-cells.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Regenerative Medicine</dc:subject>
  <dc:date>2013-01-07</dc:date>
  <dc:creator>Select Biosciences, Ltd.</dc:creator>
  <title>Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2013</title>
  <link>http://www.giiresearch.com/report/sb227611-circulating-tumor-cells-ctcs-cancer-stem-cells.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg259016-cancer-peptides-from-first-class-best-class.html">
  <dc:language>en</dc:language>
  <dc:subject>Biologics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2013-01-07</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Cancer Peptides: From First-in-Class to Best-in-Class?</title>
  <link>http://www.giiresearch.com/report/bg259016-cancer-peptides-from-first-class-best-class.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/grey135878-clos-drug-trans-onco.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-01-02</dc:date>
  <dc:creator>Greystone Research Associates</dc:creator>
  <title>Closed Drug Transfer Systems: Therapeutic Markets, Strategies and Outlook</title>
  <link>http://www.giiresearch.com/report/grey135878-clos-drug-trans-onco.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc257331-prevention-treatment-prostate-cancer-technologies.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2013-01-01</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Prevention and Treatment of Prostate Cancer: Technologies and Global Markets</title>
  <link>http://www.giiresearch.com/report/bc257331-prevention-treatment-prostate-cancer-technologies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi258791-liver-cancer-therapeutics-market-nexavar-only.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail</title>
  <link>http://www.giiresearch.com/report/gbi258791-liver-cancer-therapeutics-market-nexavar-only.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262444-pharmapoint-prostate-cancer-united-states-drug.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>PharmaPoint: Prostate Cancer - United States Drug Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262444-pharmapoint-prostate-cancer-united-states-drug.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262446-pharmapoint-prostate-cancer-france-drug-forecast.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>PharmaPoint: Prostate Cancer - France Drug Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262446-pharmapoint-prostate-cancer-france-drug-forecast.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262450-pharmapoint-prostate-cancer-japan-drug-forecast.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>PharmaPoint: Prostate Cancer - Japan Drug Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262450-pharmapoint-prostate-cancer-japan-drug-forecast.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262469-zoladex-prostate-cancer-forecast-market-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Zoladex (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262469-zoladex-prostate-cancer-forecast-market-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262470-lupron-depot-prostate-cancer-forecast-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Lupron Depot (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262470-lupron-depot-prostate-cancer-forecast-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262471-eligard-prostate-cancer-forecast-market-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Eligard (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262471-eligard-prostate-cancer-forecast-market-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262472-trelstar-prostate-cancer-forecast-market-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Trelstar (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262472-trelstar-prostate-cancer-forecast-market-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262473-firmagon-prostate-cancer-forecast-market-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Firmagon (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262473-firmagon-prostate-cancer-forecast-market-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262474-jevtana-prostate-cancer-forecast-market-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Jevtana (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262474-jevtana-prostate-cancer-forecast-market-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262475-provenge-prostate-cancer-forecast-market-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Provenge (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262475-provenge-prostate-cancer-forecast-market-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262476-zytiga-prostate-cancer-forecast-market-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Zytiga (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262476-zytiga-prostate-cancer-forecast-market-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262477-xtandi-prostate-cancer-forecast-market-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Xtandi (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262477-xtandi-prostate-cancer-forecast-market-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262478-xgeva-prostate-cancer-forecast-market-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Xgeva (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262478-xgeva-prostate-cancer-forecast-market-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262479-zometa-prostate-cancer-forecast-market-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Zometa (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262479-zometa-prostate-cancer-forecast-market-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262480-cabozantinib-prostate-cancer-forecast-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Cabozantinib (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262480-cabozantinib-prostate-cancer-forecast-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262481-custirsen-sodium-prostate-cancer-forecast-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Custirsen Sodium (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262481-custirsen-sodium-prostate-cancer-forecast-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262482-sprycel-prostate-cancer-forecast-market-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Sprycel (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262482-sprycel-prostate-cancer-forecast-market-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262483-yervoy-prostate-cancer-forecast-market-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Yervoy (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262483-yervoy-prostate-cancer-forecast-market-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262484-orteronel-prostate-cancer-forecast-market-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Orteronel (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262484-orteronel-prostate-cancer-forecast-market-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262485-alpharadin-prostate-cancer-forecast-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Alpharadin (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262485-alpharadin-prostate-cancer-forecast-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262486-tasquinimod-prostate-cancer-forecast-market.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Tasquinimod (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262486-tasquinimod-prostate-cancer-forecast-market.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd262487-prostvac-prostate-cancer-forecast-market-analysis.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Prostvac (Prostate Cancer) - Forecast and Market Analysis to 2022</title>
  <link>http://www.giiresearch.com/report/gd262487-prostvac-prostate-cancer-forecast-market-analysis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd263601-pharmapoint-prostate-cancer-current-future-players.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-12-31</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>PharmaPoint: Prostate Cancer - Current and Future Players</title>
  <link>http://www.giiresearch.com/report/gd263601-pharmapoint-prostate-cancer-current-future-players.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd258691-epicast-report-colorectal-cancer-epidemiology.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-12-28</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>EpiCast Report: Colorectal Cancer Epidemiology Forecast to 2022</title>
  <link>http://www.giiresearch.com/report/gd258691-epicast-report-colorectal-cancer-epidemiology.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc258417-forecast-non-small-cell-lung-cancer-china.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-12-12</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Forecast: Non-Small Cell Lung Cancer in China</title>
  <link>http://www.giiresearch.com/report/dc258417-forecast-non-small-cell-lung-cancer-china.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kt226942-small-molecule-targeted-cancer-therapies-world.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Molecular Targeted Therapeutics</dc:subject>
  <dc:date>2012-12-10</dc:date>
  <dc:creator>Visiongain</dc:creator>
  <title>Small-Molecule Targeted Cancer Therapies: World Market 2013-2023</title>
  <link>http://www.giiresearch.com/report/kt226942-small-molecule-targeted-cancer-therapies-world.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc258416-treatment-non-small-cell-lung-cancer-china.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-12-10</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Treatment: Non-Small Cell Lung Cancer in China</title>
  <link>http://www.giiresearch.com/report/dc258416-treatment-non-small-cell-lung-cancer-china.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/kl258246-next-wave-cancer-treatment-kinase-inhibitors.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Molecular Targeted Therapeutics</dc:subject>
  <dc:date>2012-12-04</dc:date>
  <dc:creator>Kalorama Information</dc:creator>
  <title>The Next Wave In Cancer Treatment - Kinase Inhibitors</title>
  <link>http://www.giiresearch.com/report/kl258246-next-wave-cancer-treatment-kinase-inhibitors.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bc256178-oncology-market-research-review.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-12-01</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>2012 Oncology Market Research Review</title>
  <link>http://www.giiresearch.com/report/bc256178-oncology-market-research-review.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gd212843-cervical-cancer-global-clinical-trials-review-h2.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-11-30</dc:date>
  <dc:creator>GlobalData</dc:creator>
  <title>Cervical Cancer Global Clinical Trials Review, H2, 2012</title>
  <link>http://www.giiresearch.com/report/gd212843-cervical-cancer-global-clinical-trials-review-h2.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr270349-treatmenttrends-advanced-metastatic-breast-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-11-30</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>TreatmentTrends : Advanced/Metastatic Breast Cancer (US) 2012</title>
  <link>http://www.giiresearch.com/report/dr270349-treatmenttrends-advanced-metastatic-breast-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr270345-oncology-patient-flow-model-ovarian-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-11-28</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>Oncology Patient Flow Model: Ovarian Cancer</title>
  <link>http://www.giiresearch.com/report/dr270345-oncology-patient-flow-model-ovarian-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr270339-launchtrends-enzalutimide-xtandi-wave-1-us.html">
  <dc:language>en</dc:language>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-11-26</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>LaunchTrends : Enzalutimide (Xtandi) (Wave 1) US 2012</title>
  <link>http://www.giiresearch.com/report/dr270339-launchtrends-enzalutimide-xtandi-wave-1-us.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr270336-innovative-r-d-dealmaking-opportunities-oncology.html">
  <dc:language>en</dc:language>
  <dc:subject>Molecular Targeted Therapeutics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-11-21</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>Innovative R&amp;D and Dealmaking Opportunities: Oncology - Novel Targeted Small-Molecule Therapies</title>
  <link>http://www.giiresearch.com/report/dr270336-innovative-r-d-dealmaking-opportunities-oncology.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr270272-chemotherapy-induced-nausea-vomiting-how-are.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-11-16</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>Chemotherapy-Induced Nausea and Vomiting: How Are Payers, Prescribers, and Oncology Nurses Shaping This Buoyant Market?</title>
  <link>http://www.giiresearch.com/report/dr270272-chemotherapy-induced-nausea-vomiting-how-are.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr270344-oncology-patient-flow-model-non-small-cell-lung.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-11-16</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>Oncology Patient Flow Model: Non-Small-Cell Lung Cancer</title>
  <link>http://www.giiresearch.com/report/dr270344-oncology-patient-flow-model-non-small-cell-lung.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr270354-treatmenttrends-non-small-cell-lung-cancer-eu.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-11-16</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>TreatmentTrends : Non-Small-Cell Lung Cancer (EU) 2012</title>
  <link>http://www.giiresearch.com/report/dr270354-treatmenttrends-non-small-cell-lung-cancer-eu.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc256959-hemophilia-pipeline-overview-once-week-prophylaxis.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Drug Discovery</dc:subject>
  <dc:date>2012-11-12</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Hemophilia Pipeline Overview - Once-a-week prophylaxis may soon become a reality</title>
  <link>http://www.giiresearch.com/report/dc256959-hemophilia-pipeline-overview-once-week-prophylaxis.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr270340-launchtrends-xalkori-wave-3.html">
  <dc:language>en</dc:language>
  <dc:subject>Prescription Drugs</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-11-09</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>LaunchTrends : Xalkori (Wave 3) 2012</title>
  <link>http://www.giiresearch.com/report/dr270340-launchtrends-xalkori-wave-3.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dr270343-oncology-patient-flow-model-head-neck-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-11-09</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>Oncology Patient Flow Model: Head and Neck Cancer</title>
  <link>http://www.giiresearch.com/report/dr270343-oncology-patient-flow-model-head-neck-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/fs253869-united-states-oncology-drug-delivery-preferences.html">
  <dc:language>en</dc:language>
  <dc:subject>Drug Delivery System</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-11-02</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery</title>
  <link>http://www.giiresearch.com/report/fs253869-united-states-oncology-drug-delivery-preferences.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/tk243424-game-changers-breast-cancer-therapies.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-11-01</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>Breast Cancer Therapies Markets</title>
  <link>http://www.giiresearch.com/report/tk243424-game-changers-breast-cancer-therapies.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/gbi253371-leukemia-therapeutics-market-strong-late-stage.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-11-01</dc:date>
  <dc:creator>GBI Research</dc:creator>
  <title>Leukemia Therapeutics Market to 2018 - Strong Late-stage Pipeline to Sustain Branded Drugs' Major Market Share</title>
  <link>http://www.giiresearch.com/report/gbi253371-leukemia-therapeutics-market-strong-late-stage.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/bg254187-cancer-antibodies-drug-target-atlas-competitive.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:subject>Biologics</dc:subject>
  <dc:date>2012-11-01</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Cancer Antibodies: Drug Target Atlas and Competitive OutlookAdditional Information</title>
  <link>http://www.giiresearch.com/report/bg254187-cancer-antibodies-drug-target-atlas-competitive.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/tsm253512-cervical-cancer-diagnostic-tests-pap-smear.html">
  <dc:language>en</dc:language>
  <dc:subject>In Vitro Diagnostics</dc:subject>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-10-26</dc:date>
  <dc:creator>Transparency Market Research</dc:creator>
  <title>Cervical Cancer Diagnostic Tests (Pap Smear, Colposcopy And Ecc Procedures) Market - Global Industry Analysis By Test Type And Age Group, Market Size, Share And Forecast, 2012 - 2018</title>
  <link>http://www.giiresearch.com/report/tsm253512-cervical-cancer-diagnostic-tests-pap-smear.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc254480-market-product-forecasts-melanoma-yervoy-will.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-10-23</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Market and Product Forecasts: Melanoma - Yervoy will continue to dominate as new approvals struggle to compete</title>
  <link>http://www.giiresearch.com/report/dc254480-market-product-forecasts-melanoma-yervoy-will.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/dc254476-treatment-algorithms-non-small-cell-lung-cancer.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-10-09</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Treatment Algorithms: Non-Small Cell Lung Cancer -  Molecular profiling will increasingly guide the choice of therapy</title>
  <link>http://www.giiresearch.com/report/dc254476-treatment-algorithms-non-small-cell-lung-cancer.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/amid125555-china-cancer-treatment.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-10-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development</dc:creator>
  <title>Chinese Markets for Cancer Treatment Drugs</title>
  <link>http://www.giiresearch.com/report/amid125555-china-cancer-treatment.html</link>
  <description></description>
</item>
<item rdf:about="http://www.giiresearch.com/report/cd251782-therapies-solid-tumors-pipelines-markets-business.html">
  <dc:language>en</dc:language>
  <dc:subject>Cancer</dc:subject>
  <dc:date>2012-09-30</dc:date>
  <dc:creator>Insight Pharma Reports</dc:creator>
  <title>Therapies for Solid Tumors: Pipelines, Markets, and Business Considerations - Overview</title>
  <link>http://www.giiresearch.com/report/cd251782-therapies-solid-tumors-pipelines-markets-business.html</link>
  <description></description>
</item>
</rdf:RDF>